Valuation Sunflower Pharmaceutical Group Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 30/10/2026			5-day change	1st Jan Change
11.85 ^CNY	+4.50%		+6.66%	-19.77%

10-30	Sunflower Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
10-14	Sunflower Pharmaceutical Gets Board Nod to Cancel Wholly-Owned Subsidiary	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	8,527	9,495	13,469	15,172	11,966	8,626
Change	-	11.35%	41.85%	12.65%	-21.13%	-27.92%
Enterprise Value (EV) ¹	6,889	7,446	10,057	11,597	9,677	6,134
Change	-	8.08%	35.07%	15.31%	-16.56%	-36.62%
P/E	14.7x	13.6x	15.7x	13.5x	24.4x	-33.6x
PBR	2.66x	2.61x	3.22x	3.19x	2.73x	2.25x
PEG	-	0.6x	0.7x	0.5x	-0.4x	0x
Capitalization / Revenue	2.46x	2.13x	2.64x	2.66x	3.54x	3.72x
EV / Revenue	1.99x	1.67x	1.97x	2.03x	2.87x	2.65x
EV / EBITDA	8.52x	7.97x	7.84x	8.55x	15.5x	-48.6x
EV / EBIT	10.4x	9.65x	9.84x	9.8x	21.4x	-21x
EV / FCF	10.1x	10.5x	6.48x	31x	-19.2x	10.1x
FCF Yield	9.88%	9.52%	15.4%	3.22%	-5.21%	9.89%
Dividend per Share ²	0.35	0.7	1	1.5	0.5	0.2
Rate of return	2.39%	4.25%	4.31%	5.77%	2.44%	1.35%
EPS ²	1	1.21	1.48	1.92	0.84	-0.44
Distribution rate	35%	57.9%	67.6%	78.1%	59.5%	-45.5%
Net sales ¹	3,462	4,461	5,095	5,700	3,377	2,318
EBITDA ¹	809	933.8	1,283	1,356	625.7	-126.2
EBIT ¹	661.9	771.3	1,022	1,184	452.8	-291.6
Net income ¹	584.5	704.7	867.2	1,119	492	-257.8
Net Debt ¹	-1,638	-2,049	-3,411	-3,576	-2,289	-2,492
Reference price ²	14.67	16.46	23.18	25.98	20.49	14.77
Nbr of stocks (in thousands)	581,265	576,870	581,050	584,000	584,000	584,000
Announcement Date	4/20/21 A	4/21/22 A	4/11/23 A	4/25/24 A	4/24/25 A	4/26/26 A

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SUNFLOWER PHARMACEUTICAL GROUP CO., LTD.	-	-	-	-	994M
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	30.48x	7.29x	19.41x	2.05%	417.78B
Weighted average by Cap.	36.66x	8.71x	21.55x	1.73%